Abstract
Purpose
The outcome of XEN implantation in Chinese eyes has not been previously reported. The purpose of our study is to evaluate the efficacy and safety of combined cataract surgery and XEN implantation in Chinese eyes with glaucoma.
Methods
We conducted a prospective study of 31 consecutive Chinese patients who underwent combined phacoemulsification and XEN implantation at the National University Hospital (Singapore) in this study. Patients were assessed preoperatively and postoperatively on days 1 and 7, and months 1, 3, 6, and 12. The intraocular pressure (IOP), glaucoma medication use, Snellen visual acuity (VA), and complications were assessed at each visit. The Wilcoxon signed rank test for non-parametric data was used for the analysis of IOP and glaucoma medications at baseline versus 12 months after the procedure.
Results
The mean age of the patients was 70 ± 7.9 years and 48.4% were male. Twelve patients (38.7%) were diagnosed with primary open angle glaucoma and 19 patients (61.3%) were diagnosed with primary angle closure glaucoma. There was a significant decrease in IOP at 12 months (12.1 ± 2.6 mmHg) compared with preoperative medicated (15.6 ± 2.7 mmHg, p < 0.0001) and unmedicated IOP (22.1 ± 3.6 mmHg, p < 0.001). as well as a significant reduction in the number of glaucoma medications (1.4 ± 0.6 vs 0.1 ± 0.4, p < 0.0001). The most common complications were transient hypotony (12.9%) and ptosis (12.9%) and there were no sight-threatening intraoperative or postoperative complications. One patient required additional glaucoma surgery for uncontrolled IOP at 8 months after combined phacoemulsification and XEN implantation.
Conclusion
Combined XEN implantation with cataract surgery was effective in lowering the IOP and the number of glaucoma medications in Chinese eyes for at least 12 months, with a favorable safety profile.
Similar content being viewed by others
References
Lewis RA. Ab interno approach to the subconjunctival space using a collagen glaucoma stent. J Cat Ref Surg. 2014;40(8):1301–6.
Reitsamer H, Sng C, Vera V, et al. Two-year results of a multicenter study of ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2019;257(5):983–96.
Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80(5):389–93.
Tan C, Chew PT, Lum WL, Chee C. Trabeculectomy—success rates in a Singapore hospital. Singapore Med J. 1996;37(5):505–7.
Wong HT, Seah SK. Retrospective analysis of outcome of trabeculectomies for primary glaucoma. Asia-Pacific Ophthalmol. 1998;10:12–5.
Ng PW, Yeung BY, Yick DW, et al. Fornix-based trabeculectomy with Wise’s suture technique in Chinese patients. Ophthalmology. 2000;107(12):2310–3.
Taylor SC. Skin of color: biology, structure, function, and implications for dermatologic disease (review). J Am Acad Dermatol. 2002;46(Suppl62):S41–62.
Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery (review). Surv Ophthalmol. 2003;48(3):314–46.
Wong TY, Foster PJ, Hee J, et al. Prevalence and risk factors for refractive errors in adult Chinese in Singapore. Invest Ophthalmol Vis Sci. 2000;41(9):2486–94.
Koh V, Chen D, Aquino CM, et al. Success rates of 2-site phacoemulsification combined with fornix-based trabeculectomy using mitomycin C for primary angle-closure glaucoma and primary open-angle glaucoma in an Asian population. Jpn J Ophthalmol. 2017;61(3):245–52.
Jampel HD, Pasquale LR, Dibernardo C. Hypotony maculopathy following trabeculectomy with mitomycin C. Arch Ophthalmol. 1992;110(8):1049–50.
Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002;86(2):238–42.
Hernstadt DJ, Cheng J, Htoon HM, et al. Case series of combined iStent implantation and phacoemulsification in eyes with primary angle closure disease: one-year outcomes. Adv Ther. 2019;36(4):976–86.
Canadian Ophthalmological Society. Evidence-based clinical practice guidelines for the management of glaucoma in the adult eye. Can J Ophthalmol. 2009;44(Suppl 1):S7–93.
Parrish RK 2nd, Minckler DS, Lam D, Pfeiffer N, Rojanapongpun P. Recommended methodology for glaucoma surgical trials. In: Shaarawy TM, Sherwood MB, Grehn F, editors. World Glaucoma Association guidelines on design and reporting of glaucoma surgical trials. Amsterdam: Kugler; 2009. p. 1–14.
Sng CC, Wang J, Hau S, et al. XEN-45 collagen implant for the treatment of uveitic glaucoma. Clin Exp Ophthalmol. 2018;46(4):339–45.
Schlenker MB, Gulamhusein H, Conrad-Hengerer I, et al. Efficacy, safety and risk factors for failure of standalone ab interno gelatin microstent implantation versus standalone trabeculectomy. Ophthalmology. 2017;124(11):1579–88.
Tham CC, Kwong YY, Leung DY, et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology. 2009;116(4):725–31 (31.e1–3).
Tham CC, Kwong YY, Leung DY, et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology. 2008;115(12):2167-83.e2.
Park AJ, Eliassi-Rad B, Desai MA. Ptosis after glaucoma surgery. Clin Ophthalmol. 2017;11:1483–9.
Kaplan LJ, Jaffe NS, Clayman HM. Ptosis and cataract surgery. A multivariant computer analysis of a prospective study. Ophthalmology. 1985;92(2):237–42.
Crosby NJ, Shepherd D, Murray A. Mechanical testing of lid speculae and relationship to postoperative ptosis. Eye (Lond). 2013;27(9):1098–101.
Acknowledgements
Funding
This study and the journal’s Rapid Service Fees were funded by an endowment from the Lee Foundation (Singapore).
Authorship
All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, had full access to all of the data in this study, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
Disclosures
Chelvin C. A. Sng is a consultant for Alcon, Allergan, and Santen and has also received research and travel funding from Glaukos and Allergan. Marcus Ang is a consultant for Allergan, Ziemer, Zeiss, and Johnson & Johnson. Paul T. K. Chew, Hla Myint Htoon, Katherine Lun and Preethi Jeyabal have nothing to declare.
Compliance with Ethics Guidelines
This study was approved by the National Healthcare Group Domain Specific Review Board. Informed consent was obtained from all subjects before recruitment into this study.
Data Availability
The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Author information
Authors and Affiliations
Corresponding author
Additional information
Enhanced Digital Features
To view enhanced digital features for this article go to https://doi.org/10.6084/m9.figshare.9906713.
Rights and permissions
About this article
Cite this article
Sng, C.C.A., Chew, P.T.K., Htoon, H.M. et al. Case Series of Combined XEN Implantation and Phacoemulsification in Chinese Eyes: One-Year Outcomes. Adv Ther 36, 3519–3529 (2019). https://doi.org/10.1007/s12325-019-01127-w
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12325-019-01127-w